MedTrace Logo

Application of Probiotic PS128 in Children With ASD

NCT04942522 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-08-31

No results posted yet for this study

Summary

The purpose of this study is to explore the role of probiotics PS128 in improving gastrointestinal dysfunction and core behavioral symptoms in children with ASD, and investigate the underlying etiological mechanisms of ASD.

Conditions

Interventions

BIOLOGICAL

probiotics PS128

6×10\^10 CFU/capsule

DRUG

placebo (Microcrystalline cellulose )

450 mg/capsule

Sponsors & Collaborators

  • Yan Hao

    lead OTHER

Principal Investigators

  • Yan Hao, PhD · Tongji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
2 Years
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-06
Primary Completion
2023-06-06
Completion
2023-10-06

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04942522 on ClinicalTrials.gov